
Grifols Egypt for Plasma Derivatives (GEPD) is a pioneering joint‑venture between the Egyptian Government’s National Service Projects Organization and global plasma medicine leader Grifols. The company is building 20 plasma donation centers across Egypt and a state‑of‑the‑art manufacturing complex—encompassing fractionation, purification, and fill‑and‑finish operations—with an annual capacity of 1 million liters of plasma, expandable to 2 million liters. GEPD’s strategic location in the administrative capital’s medical city and its role as the first Egyptian source member of the Plasma Protein Therapeutics Association position it as a regional catalyst for self‑sufficiency in critical plasma‑derived therapies. By combining local expertise with Grifols’ 110‑year legacy, GEPD delivers high‑quality pharmaceutical and healthcare solutions that strengthen Egypt’s health system and advance global plasma medicine innovation.
Quality Assurance Supervisor responsible for supervising daily activities of PLC Quality Assurance staff, ensuring compliance with established procedures, and maintaining a regulated environment.
Grifols Egypt for Plasma Derivatives (GEPD) is a pioneering joint‑venture between the Egyptian Government’s National Service Projects Organization and global plasma medicine leader Grifols. The company is building 20 plasma donation centers across Egypt and a state‑of‑the‑art manufacturing complex—encompassing fractionation, purification, and fill‑and‑finish operations—with an annual capacity of 1 million liters of plasma, expandable to 2 million liters. GEPD’s strategic location in the administrative capital’s medical city and its role as the first Egyptian source member of the Plasma Protein Therapeutics Association position it as a regional catalyst for self‑sufficiency in critical plasma‑derived therapies. By combining local expertise with Grifols’ 110‑year legacy, GEPD delivers high‑quality pharmaceutical and healthcare solutions that strengthen Egypt’s health system and advance global plasma medicine innovation.
Grifols Egypt for Plasma Derivatives